Patients’ self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis

BACKGROUND: Capecitabine plus oxaliplatin (XELOX) has been established as a first-line treatment for metastatic colorectal cancer. Adherence is particularly important with capecitabine to maintain appropriate curative effect. In this study, we monitored the adherence to capecitabine on XELOX treatme...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Patient Prefer Adherence
Asıl Yazarlar: Kawakami, Kazuyoshi, Nakamoto, Eri, Yokokawa, Takashi, Sugita, Kazuo, Mae, Yutarou, Hagino, Akane, Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Oniyama, Sayaka, Machida, Yoshiaki, Yamaguchi, Toshiharu, Hama, Toshihiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4399552/
https://ncbi.nlm.nih.gov/pubmed/25914526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S80327
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller